Niagara is committed to helping people of all ages gain improvement in the important areas of health and mobility. Since introducing Cycloid Vibration Therapy (CVT) products to the USA in 1949, our Company’s vision to help people feel, move and live better led to an expansion throughout Europe, Africa & Australasia. Niagara Therapy Australasia is fully Australian Owned and originally began supplying its purpose-built products in New Zealand through independent Auckland based distributors in 1985.
Today, Niagara Healthcare NZ is fully operated via the main Company dedicating its focus to providing care, expertise, and support during all stages of a client’s journey with CVT. All Niagara CVT devices are listed with MEDSAFE as a Class IIa Medical Device so you can be confident that there have been clinical studies and testing to support our therapeutic claims.
Commencing in 1949, Niagara pioneered the development of Cycloid Vibration Therapy through ongoing product development and advice from medical professionals. This has continued throughout the decades to produce the standard of quality that our Cycloid Vibration Therapy devices are today.
Niagara Therapy recognises that people of all ages face many challenges with their health which can lead to diminished well-being, mobility, independence and lifestyle options. Our organisation has a vision for everyone to try Cycloid Vibration Therapy at least once, Free of Charge, to find out personally how Niagara CVT feels when applied to the body.
Niagara has set about establishing an extensive list of clients and networks of users throughout Australia, New Zealand, & many Asian countries. With demand for quality healthcare solutions growing across the entire Australasian region, Niagara is now in a position to manufacture, distribute and export its ARTG & Medsafe listed Class IIa Medical Devices all over the region.
All Niagara products are listed on the Australian Register of Therapeutic Goods (ARTG) and with Medsafe in New Zealand as a Class IIa Medical Device.
- Increase local area blood flow.
- Assist in the reduction of musculoskeletal pain.
- Increase joint mobilisation.
- Reduce excess oedema (Swelling) whether the cause is vascular or lymphatic.
- Assist in the treatment of wounds where an improvement in local circulation is a factor.
- Assist in the treatment of pressure ulcers where an improvement in local circulation is a factor.